tiprankstipranks
Trending News
More News >
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market
Advertisement

Anavex Life Sciences (AVXL) Income Statement

Compare
1,724 Followers

Anavex Life Sciences Income Statement

Last quarter (Q3 2025), Anavex Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Anavex Life Sciences's net income was $-13.24M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ ―$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ ―$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 51.41M$ ―$ 52.88M$ 55.76M$ 50.99M
Depreciation and Amortization
$ 0.00$ ―$ 50.59M$ -2.72M$ -3.32M
EBITDA
$ 0.00$ ―$ 5.29M$ -55.76M$ -50.94M
Operating Income
$ 0.00$ ―$ -52.88M$ -55.76M$ -50.99M
Other Income/Expenses
$ 0.00$ ―$ 9.88M$ 8.26M$ 3.37M
Pretax Income
$ 0.00$ ―$ -43.00M$ -47.50M$ -47.62M
Net Income
$ 0.00$ ―$ -43.00M$ -47.51M$ -47.98M
Per Share Metrics
Basic EPS
$ -0.54$ ―$ -0.52$ -0.60$ -0.62
Diluted EPS
$ -0.54$ ―$ -0.52$ -0.60$ -0.62
Weighted Average Shares Outstanding
85.29M 83.47M 79.79M 76.91M
Weighted Average Shares Outstanding (Diluted)
85.29M 83.47M 79.79M 76.91M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis